# ADYNOVATE Drug Use-Results Survey

> **NCT03169972** · — · COMPLETED · sponsor: **Takeda** · enrollment: 135 (actual)

## Conditions studied

- Hemophilia A

## Interventions

- **BIOLOGICAL:** ADYNOVATE

## Key facts

- **NCT ID:** NCT03169972
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-01
- **Primary completion:** 2023-09-15
- **Final completion:** 2023-09-15
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2025-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03169972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03169972, "ADYNOVATE Drug Use-Results Survey". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03169972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*